In 2022, the Chinese pharmaceutical firm Fosun Pharmaceutical generated around 44 billion yuan of revenue, representing a growth of 12.7 percent from the previous year. Although anti-infection products remained the company's most important source of income, anti-tumor and immune modulation medications, such as trastuzumab and adalimumab, contributed more than 5.5 billion yuan of Fosun's revenue in 2022, almost 40 percent more than in 2021.
Revenue generated by major products of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in 2022, by therapeutic area
(in billion yuan)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Shanghai Fosun Pharmaceutical (Group). (March 27, 2023). Revenue generated by major products of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in 2022, by therapeutic area (in billion yuan) [Graph]. In Statista. Retrieved November 10, 2024, from https://www-statista-com.ezproxy.canberra.edu.au/statistics/1403758/chinese-pharmaceuticals-fosun-revenue-from-major-products-by-therapeutic-area/
Shanghai Fosun Pharmaceutical (Group). "Revenue generated by major products of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in 2022, by therapeutic area (in billion yuan)." Chart. March 27, 2023. Statista. Accessed November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1403758/chinese-pharmaceuticals-fosun-revenue-from-major-products-by-therapeutic-area/
Shanghai Fosun Pharmaceutical (Group). (2023). Revenue generated by major products of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in 2022, by therapeutic area (in billion yuan). Statista. Statista Inc.. Accessed: November 10, 2024. https://www-statista-com.ezproxy.canberra.edu.au/statistics/1403758/chinese-pharmaceuticals-fosun-revenue-from-major-products-by-therapeutic-area/
Shanghai Fosun Pharmaceutical (Group). "Revenue Generated by Major Products of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in 2022, by Therapeutic Area (in Billion Yuan)." Statista, Statista Inc., 27 Mar 2023, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1403758/chinese-pharmaceuticals-fosun-revenue-from-major-products-by-therapeutic-area/
Shanghai Fosun Pharmaceutical (Group), Revenue generated by major products of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in 2022, by therapeutic area (in billion yuan) Statista, https://www-statista-com.ezproxy.canberra.edu.au/statistics/1403758/chinese-pharmaceuticals-fosun-revenue-from-major-products-by-therapeutic-area/ (last visited November 10, 2024)
Revenue generated by major products of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. in 2022, by therapeutic area (in billion yuan) [Graph], Shanghai Fosun Pharmaceutical (Group), March 27, 2023. [Online]. Available: https://www-statista-com.ezproxy.canberra.edu.au/statistics/1403758/chinese-pharmaceuticals-fosun-revenue-from-major-products-by-therapeutic-area/
